# XtalPi and Pierre Fabre agree to AI-driven oncology drug discovery collaboration

> Original title: 皮尔法伯集团与晶泰科技达成AI驱动药物发现合作，将在肿瘤领域联合开展多个研发项目

- Source: Leiphone
- Published: 2026-11-09T07:28:00.000Z
- Bad Influence: https://badinfluence.news/items/dtir9azheryuqas3vl63s0z7k
- Original: https://www.leiphone.com/category/shengwuyiyao/HMCKdmWiZA0bT07Q.html

## Summary

XtalPi and Pierre Fabre announced on November 6, 2026 a collaboration agreement to jointly run several oncology R&D projects and discover new clinical drug candidates. XtalPi will use its integrated "AI+robotics" platform to design and deliver novel small-molecule therapies de novo against undisclosed targets, while Pierre Fabre will select and advance the most promising compounds through clinical and commercial development. The deal includes an upfront payment, milestone payments and future revenue sharing; financial terms were not disclosed.